Monitoring with Limited Information
暂无分享,去创建一个
[1] Maryl R. Johnson,et al. When is retransplantation a viable option? , 2007, Heart failure clinics.
[2] H. Leland.. Corporate Debt Value, Bond Covenants, and Optimal Capital Structure , 1994, World Scientific Reference on Contingent Claims Analysis in Corporate Finance.
[3] Erick Delage,et al. Robust Multistage Decision Making , 2015 .
[4] L. Edmunds,et al. The Annals of Thoracic Surgery. , 2014, The Annals of thoracic surgery.
[5] J. Poterba,et al. Speculative Dynamics , 1990 .
[6] P. Wilmott,et al. Option pricing: Mathematical models and computation , 1994 .
[7] Arkadi Nemirovski,et al. Robust optimization – methodology and applications , 2002, Math. Program..
[8] Omid Nohadani,et al. Robust optimization with time-dependent uncertainty in radiation therapy , 2017 .
[9] Fernando Zapatero,et al. Monte Carlo Valuation of American Options through Computation of the Optimal Exercise Frontier , 2000, Journal of Financial and Quantitative Analysis.
[10] Nilay D Shah,et al. Optimizing the Start Time of Statin Therapy for Patients with Diabetes , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.
[11] Mayank Sharma,et al. Supermodularity and Affine Policies in Dynamic Robust Optimization , 2013, Oper. Res..
[12] Bob Kiaii,et al. Early and late outcomes after cardiac retransplantation. , 2013, Canadian journal of surgery. Journal canadien de chirurgie.
[13] Michael Poss,et al. Robust combinatorial optimization with variable budgeted uncertainty , 2012, 4OR.
[14] John Lygeros,et al. Robust optimal control with adjustable uncertainty sets , 2015, Autom..
[15] R. Hays,et al. Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease , 2003, Health and quality of life outcomes.
[16] D. Bertsimas,et al. Data-driven learning in dynamic pricing using adaptive optimization , 2014 .
[17] Anees J. Razzouk,et al. Cardiac retransplantation , 2000 .
[18] Omid Nohadani,et al. Optimization under Decision-Dependent Uncertainty , 2016, SIAM J. Optim..
[19] W. Mahle,et al. Cost‐Effectiveness of Pediatric Heart Transplantation Across a Positive Crossmatch for High Waitlist Urgency Candidates , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[20] Ali Montazeri,et al. Health and Quality of Life Outcomes , 2009 .
[21] Fernando Paganini,et al. A Course in Robust Control Theory , 2000 .
[22] I. Karatzas,et al. Optimal Stopping for Dynamic Convex Risk Measures , 2009, 0909.4948.
[23] Dick den Hertog,et al. When are static and adjustable robust optimization problems with constraint-wise uncertainty equivalent? , 2017, Math. Program..
[24] Ananth Raman,et al. Inventory-Based Lending Industry Note , 2012 .
[25] B Schnetzler,et al. Heart retransplantation: a 23-year single-center clinical experience. , 1998, The Annals of thoracic surgery.
[26] Turgay Ayer,et al. OR Forum - A POMDP Approach to Personalize Mammography Screening Decisions , 2012, Oper. Res..
[27] Mark Johnson,et al. Heart Retransplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[28] Ghassan S Kassab,et al. Cardiac allograft vasculopathy: Microvascular arteriolar capillaries ('capioles") and survival. , 2017, Frontiers in bioscience.
[29] Clive Lewis,et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[30] Elisa F. Long,et al. Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure , 2014, Circulation. Heart failure.
[31] Dimitris Bertsimas,et al. Tractable stochastic analysis in high dimensions via robust optimization , 2012, Mathematical Programming.
[32] Alexander Schrijver,et al. Combinatorial optimization. Polyhedra and efficiency. , 2003 .
[33] Erhan Bayraktar,et al. On the Robust Optimal Stopping Problem , 2013, SIAM J. Control. Optim..
[34] J. Copeland,et al. Elective cardiac retransplantation: a viable option that can be repeated. , 2011, The Journal of thoracic and cardiovascular surgery.
[35] C. Tinelli,et al. Should we perform heart retransplantation in early graft failure? , 2010, Transplant international : official journal of the European Society for Organ Transplantation.
[36] Lisa M. Maillart,et al. Assessing Dynamic Breast Cancer Screening Policies , 2008, Oper. Res..
[37] Andrew J. Schaefer,et al. The Optimal Time to Initiate HIV Therapy Under Ordered Health States , 2008, Oper. Res..
[38] S. Shreve,et al. Methods of Mathematical Finance , 2010 .
[39] John Schoenmakers,et al. Iterative construction of the optimal Bermudan stopping time , 2006, Finance Stochastics.
[40] Dimitris Bertsimas,et al. A tight characterization of the performance of static solutions in two-stage adjustable robust linear optimization , 2014, Math. Program..
[41] H. M. Taylor. Optimal Stopping in a Markov Process , 1968 .
[42] William J. Morris,et al. When to treat prostate cancer patients based on their PSA dynamics , 2012 .
[43] Fabio Tardella,et al. Bimonotone linear inequalities and sublattices of Rn , 2006 .
[44] D. M. Topkis. Supermodularity and Complementarity , 1998 .
[45] M. Wilhelm. Long-term outcome following heart transplantation: current perspective. , 2015, Journal of thoracic disease.
[46] R. Starling,et al. Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trial. , 2013, JACC. Heart failure.
[47] R. Lanza,et al. Further cardiac transplant procedures in patients with heterotopic heart transplants. , 1985, The Annals of thoracic surgery.
[48] R. Rajan,et al. Covenants and Collateral as Incentives to Monitor , 1995 .
[49] Walter S. Seidman. Accounts receivable and inventory financing , 1957 .
[50] L. Goldraich,et al. Retransplant and Medical Therapy for Cardiac Allograft Vasculopathy: International Society for Heart and Lung Transplantation Registry Analysis , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[51] A. Ben-Tal,et al. Adjustable robust solutions of uncertain linear programs , 2004, Math. Program..
[52] J. Snell. Applications of martingale system theorems , 1952 .
[53] H. Leland.,et al. Optimal Capital Structure, Endogenous Bankruptcy, and the Term Structure of Credit Spreads , 1996, World Scientific Reference on Contingent Claims Analysis in Corporate Finance.
[54] W. von Scheidt,et al. Cardiac allograft vasculopathy: a review. , 1997, Circulation.
[55] T. S. Ng,et al. Satisficing Awakens : Models to Mitigate Uncertainty , 2016 .
[56] Constantine Caramanis,et al. Theory and Applications of Robust Optimization , 2010, SIAM Rev..
[57] M C Oz,et al. Long-term survival after cardiac retransplantation: a twenty-year single-center experience. , 1999, The Journal of thoracic and cardiovascular surgery.
[58] Laurent El Ghaoui,et al. Robust Optimization , 2021, ICORES.
[59] M. Machina. Dynamic Consistency and Non-expected Utility Models of Choice under Uncertainty , 1989 .
[60] Jon Kobashigawa,et al. What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy? , 2000, Current controlled trials in cardiovascular medicine.
[61] F. Riedel. Optimal Stopping With Multiple Priors , 2009 .
[62] C. Knosalla,et al. Impact of Donor-transmitted Coronary Atherosclerosis on Quality of Life (QOL) and Quality-adjusted Life Years (QALY) after Heart Transplantation , 2010 .